儿童脑动静脉畸形伽玛刀治疗后远期不良辐射效应的长期结局:第二部分——囊肿形成、包裹性血肿与放射性肿瘤的发生率
本研究为单机构研究,纳入1991至2014年间接受伽玛刀放射外科治疗的201例儿童脑动静脉畸形患者,其中189例随访至少12个月。中位治疗体积2.2 cm³,中位边缘剂量20 Gy,平均随访136个月。症状性放射性病灶周围水肿5例(3%),囊肿形成7例(4%),包裹性血肿7例(4%),放射性肿瘤2例(1%);晚期不良辐射效应累积发生率5年1.2%、8年5.2%、10年6.1%、15年7.2%、20年17.0%。多因素分析中仅治疗体积为晚期不良辐射效应的显著因素(P<0.001;风险比1.111)。作者认为伽玛刀是儿童脑动静脉畸形的合理治疗选择,但需关注晚期不良辐射效应。
要点
- 儿童脑动静脉畸形伽玛刀治疗后晚期不良辐射效应20年累积发生率为17.0%。
- 症状性放射性病灶周围水肿发生率3%,囊肿形成4%,包裹性血肿4%,放射性肿瘤1%。
- 多因素分析中治疗体积是晚期不良辐射效应的显著因素(P<0.001;风险比1.111)。
核心结论
- 伽玛刀放射外科是儿童脑动静脉畸形的合理治疗选择,可预防未来颅内出血,尤其位于功能区者。
- 由于儿童预期寿命较长,应充分关注囊肿形成、包裹性血肿和放射性肿瘤等晚期不良辐射效应。
研究设计与样本
- 单机构研究,纳入1991至2014年间接受伽玛刀放射外科治疗的儿童脑动静脉畸形患者(年龄≤15岁)。
- 201例患者中189例随访至少12个月纳入分析;中位治疗体积2.2 cm³,中位边缘剂量20 Gy。
主要发现
- 平均随访136个月;症状性放射性病灶周围水肿5例(3%),囊肿形成7例(4%),包裹性血肿7例(4%),放射性肿瘤2例(1%)。
- 晚期不良辐射效应(包括囊肿形成、包裹性血肿和放射性肿瘤)累积发生率:5年1.2%、8年5.2%、10年6.1%、15年7.2%、20年17.0%。
- 多因素分析中,仅治疗体积是晚期不良辐射效应的显著因素(P<0.001;风险比1.111)。
临床怎么用
- 作者认为伽玛刀放射外科是儿童脑动静脉畸形的合理治疗选择,可预防未来颅内出血,尤其位于功能区者。
- 作者指出应充分关注囊肿形成、包裹性血肿和放射性肿瘤等晚期不良辐射效应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Long-term data about the incidence of late adverse radiation effects (AREs) in pediatric brain arteriovenous malformations (AVMs) treated with Gamma Knife radiosurgery (GKRS) are lacking. This study addresses the incidence of late AREs, including cyst formation (CF), chronic encapsulated hematoma (CEH), and radiation-induced tumor, in pediatric patients with AVM treated with GKRS. METHODS: This is a single-institutional study involving pediatric patients with AVM who underwent GKRS between 1991 and 2014. Among 201 pediatric patients with AVM (age ≤15 years), 189 who had at least 12 months of follow-up were assessed in this study. The median treatment volume was 2.2 cm3, and the median marginal dose was 20 Gy. RESULTS: The mean follow-up period was 136 months. During the follow-up period, symptomatic radiation-induced perilesional edema was found in 5 patients (3%), CFs in 7 patients (4%), CEHs in 7 patients (4%), and radiation-induced tumors in 2 patients (1%). The cumulative incidences of late AREs including CF, CEH, and radiation-induced tumor were 1.2% at 5 years, 5.2% at 8 years, 6.1% at 10 years, 7.2% at 15 years, and 17.0% at 20 years. In the multivariate analysis, treatment volume alone was a significant factor for late AREs (P < 0.001; hazard ratio, 1.111). CONCLUSIONS: GKRS is a reasonable treatment option for pediatric AVMs to prevent future intracranial hemorrhages, particularly in the eloquent regions. However, considerable attention should be paid to late AREs such as CFs, CEHs, and radiation-induced tumors because of longer life expectancy in pediatric patients.
引用
- Hasegawa T, Kato T, Naito T, et al. Long-Term Outcomes for Pediatric Patients with Brain Arteriovenous Malformations Treated with Gamma Knife Radiosurgery, Part 2: The Incidence of Cyst Formation, Encapsulated Hematoma, and Radiation-Induced Tumor. World Neurosurg. 2019. PMID: 30922905. doi:10.1016/j.wneu.2019.03.177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。